New insights into gastrointestinal and hepatic granulomatous disorders

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 8, 2011, Pages 455-466

  Almadi, Majid A ^a   Aljebreen, Abdulrahman M ^a   Sanai, Faisal M ^b   Marcus, Victoria ^c   AlMeghaiseeb, Ebtissam S ^d   Ghosh, Subrata ^e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA INTERFERON; ETANERCEPT; GAMMA GLUTAMYLTRANSFERASE; INFLIXIMAB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ADAPTIVE IMMUNITY; APPENDICITIS; BEHCET DISEASE; BLAU SYNDROME; CHOLESTASIS; CHRONIC GRANULOMATOUS DISEASE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FECES ANALYSIS; GASTROINTESTINAL GRANULOMA; GENETIC PREDISPOSITION; GRANULOMATOSIS; GRANULOMATOUS APPENDICITIS; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE TUBERCULOSIS; LIVER GRANULOMA; NONHUMAN; OCULAR ALBINISM; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SCHISTOSOMIASIS; TUBERCULIN TEST; VIRUS HEPATITIS; WEGENER GRANULOMATOSIS;

ADAPTIVE IMMUNITY; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL DISEASES; GRANULOMA; HUMANS; IMMUNITY, INNATE; LIVER DISEASES;

EID: 80051487200     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.115     Document Type: Review

References (120)

1. Infante-Duarte, C. & Kamradt, T. Th1/Th2 balance in infection. Springer Semin. Immunopathol. 21, 317-338 (1999). (Pubitemid 30011442)
2. Saunders, B. M. & Britton, W. J. Life and death in the granuloma: immunopathology of tuberculosis. Immunol. Cell Biol. 85, 103-111 (2007). (Pubitemid 46398725)
3. Vanhoutte, F. et al. Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology. Microbes Infect. 9, 1606-1613 (2007). (Pubitemid 350225744)
4. Velayudham, A. et al. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J. Hepatol. 45, 813-824 (2006). (Pubitemid 44646677)
5. Abath, F. G., Morais, C. N., Montenegro, C. E., Wynn, T. A. & Montenegro, S. M. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol. 22, 85-91 (2006). (Pubitemid 43145868)
6. Magalhaes, K. G. et al. Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through Toll-like receptor-2-dependent mechanisms. J. Infect. Dis. 202, 1369-1379 (2010).
7. Ehlers, S. Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept? Clin. Infect. Dis. 41 (Suppl. 3), S199-S203 (2005). (Pubitemid 41022091)
8. Furst, D. E., Wallis, R., Broder, M. & Beenhouwer, D. O. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin. Arthritis Rheum. 36, 159-167 (2006). (Pubitemid 44691882)
9. Olleros, M. L. et al. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am. J. Pathol. 166, 1109-1120 (2005). (Pubitemid 40524435)
10. Chakravarty, S. D. et al. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76, 916-926 (2008). (Pubitemid 351428050)
11. Clay, H., Volkman, H. E. & Ramakrishnan, L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29, 283-294 (2008).
12. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. & Altare, F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10, 943-948 (2009).
13. van Duist, M. M. et al. A new CARD15 mutation in Blau syndrome. Eur. J. Hum. Genet. 13, 742-747 (2005).
14. Henckaerts, L. & Vermeire, S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm. Bowel Dis. 13, 235-241 (2007). (Pubitemid 46806233)
15. McGovern, D. P., Van Heel, D. A., Negoro, K., Ahmad, T. & Jewell, D. P. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am. J. Hum. Genet. 73, 1465-1466 (2003). (Pubitemid 38037438)
16. Hussain, N. et al. Intestinal disease in Hermansky-Pudlak syndrome: occurrence of colitis and relation to genotype. Clin. Gastroenterol. Hepatol. 4, 73-80 (2006). (Pubitemid 43129527)
17. Koker, M. Y. et al. Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Eur. J. Clin. Invest. 39, 311-319 (2009).
18. Bustamante, J. et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat. Immunol. 12, 213-221 (2011).
19. Kakazu, T. et al. Type 1 T-helper cell predominance in granulomas of Crohn's disease. Am. J. Gastroenterol. 94, 2149-2155 (1999). (Pubitemid 29374546)
20. Heresbach, D. et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis. Eur. J. Gastroenterol. Hepatol. 16, 55-62 (2004). (Pubitemid 39043703)
21. Molnar, T., Tiszlavicz, L., Gyulai, C., Nagy, F. & Lonovics, J. Clinical significance of granuloma in Crohn's disease. World J. Gastroenterol. 11, 3118-3121 (2005). (Pubitemid 40790673)
22. Rubio, C. A., Orrego, A., Nesi, G. & Finkel, Y. Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis. J. Clin. Pathol. 60, 1268-1272 (2007). (Pubitemid 350084550)
23. Mahadeva, U., Martin, J. P., Patel, N. K. & Price, A. B. Granulomatous ulcerative colitis: A re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology 41, 50-55 (2002). (Pubitemid 34779681)
24. Cullen, G. et al. Long-term clinical results of ileocecal resection for Crohn's disease. Inflamm. Bowel Dis. 13, 1369-1373 (2007). (Pubitemid 350206847)
25. Ramzan, N. N., Leighton, J. A., Heigh, R. I. & Shapiro, M. S. Clinical significance of granuloma in Crohn's disease. Inflamm. Bowel Dis. 8, 168-173 (2002). (Pubitemid 34546042)
26. Leong, R. W. et al. Association of intestinal granulomas with smoking, phenotype, and serology in Chinese patients with Crohn's disease. Am. J. Gastroenterol. 101, 1024-1029 (2006). (Pubitemid 43725316)
27. Pierik, M. et al. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut 54, 223-227 (2005). (Pubitemid 40139238)
28. Marshall, J. B. Tuberculosis of the gastrointestinal tract and peritoneum. Am. J. Gastroenterol. 88, 989-999 (1993). (Pubitemid 23191085)
29. Almadi, M. A., Ghosh, S. & Aljebreen, A. M. Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge. Am. J. Gastroenterol. 104, 1003-1012 (2009).
30. Alvares, J. F., Devarbhavi, H., Makhija, P., Rao, S. & Kottoor, R. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy 37, 351-356 (2005). (Pubitemid 40561659)
31. Pulimood, A. B. et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn's disease from tuberculosis. Gut 45, 537-541 (1999). (Pubitemid 29447821)
32. Pulimood, A. B. et al. Differentiation of Crohn's disease from intestinal tuberculosis in India in 2010. World J. Gastroenterol. 17, 433-443 (2011).
33. Gan, H. T., Chen, Y. Q., Ouyang, Q., Bu, H. & Yang, X. Y. Differentiation between intestinal tuberculosis and Crohn's disease in endoscopic biopsy specimens by polymerase chain reaction. Am. J. Gastroenterol. 97, 1446-1451 (2002). (Pubitemid 34664790)
34. Farhat, M., Greenaway, C., Pai, M. & Menzies, D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 10, 1192-1204 (2006). (Pubitemid 44713473)
35. Pai, M., Zwerling, A. & Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149, 177-184 (2008).
36. Pai, M., Riley, L. W. & Colford, J. M. Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4, 761-776 (2004).
37. Kim, B. J. et al. Prospective evaluation of the clinical utility of interferon-gamma assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease. Inflamm. Bowel Dis. 17, 1308-1313 (2011).
38. Belard, E. et al. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm. Bowel Dis. doi:10.1002/ibd.21605.
39. Thomas, T. A. et al. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics 126, e1522-e1529 (2010).
40. Steinmann, P., Keiser, J., Bos, R., Tanner, M. & Utzinger, J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6, 411-425 (2006). (Pubitemid 43949139)
41. Strickland, G. T. Gastrointestinal manifestations of schistosomiasis. Gut 35, 1334-1337 (1994). (Pubitemid 24310884)
42. Ross, A. G. et al. Schistosomiasis. N. Engl. J. Med. 346, 1212-1220 (2002). (Pubitemid 34984584)
43. Gryseels, B., Polman, K., Clerinx, J. & Kestens, L. Human schistosomiasis. Lancet 368, 1106-1118 (2006). (Pubitemid 44402679)
44. Guillevin, L., Le Thi Huong, D., Godeau, P., Jais, P. & Wechsler, B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br. J. Rheumatol. 27, 258-264 (1988).
45. Kaneki, T. et al. Churg-Strauss syndrome (allergic granulomatous angitis) presenting with ileus caused by ischemic ileal ulcer. J. Gastroenterol. 33, 112-116 (1998). (Pubitemid 28067785)
46. Bayraktar, Y., Ozaslan, E. & Van Thiel, D. H. Gastrointestinal manifestations of Behcet's disease. J. Clin. Gastroenterol. 30, 144-154 (2000). (Pubitemid 30148442)
47. Ebert, E. C. Gastrointestinal manifestations of Behcet's disease. Dig. Dis. Sci. 54, 201-207 (2009).
48. Naganuma, M. et al. A case of Behcet's disease accompanied by colitis with longitudinal ulcers and granuloma. J. Gastroenterol. Hepatol. 17, 105-108 (2002). (Pubitemid 34304397)
49. Storesund, B., Gran, J. T. & Koldingsnes, W. Severe intestinal involvement in Wegener's granulomatosis: report of two cases and review of the literature. Br. J. Rheumatol. 37, 387-390 (1998).
50. Haworth, S. J. & Pusey, C. D. Severe intestinal involvement in Wegener's granulomatosis. Gut 25, 1296-1300 (1984). (Pubitemid 15201393)
51. Chow, F. Y., Hooke, D. & Kerr, P. G. Severe intestinal involvement in Wegener's granulomatosis. J. Gastroenterol. Hepatol. 18, 749-750 (2003). (Pubitemid 36791720)
52. Geraghty, J., Mackay, I. R. & Smith, D. C. Intestinal perforation in Wegener's granulomatosis. Gut 27, 450-451 (1986). (Pubitemid 16102902)
53. Pickhardt, P. J. & Curran, V. W. Fulminant enterocolitis in Wegener's granulomatosis: CT findings with pathologic correlation. AJR Am. J. Roentgenol. 177, 1335-1337 (2001). (Pubitemid 33081476)
54. Rybicki, B. A., Major, M., Popovich, J. Jr, Maliarik, M. J. & Iannuzzi, M. C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am. J. Epidemiol. 145, 234-241 (1997).
55. Ebert, E. C., Kierson, M. & Hagspiel, K. D. Gastrointestinal and hepatic manifestations of sarcoidosis. Am. J. Gastroenterol. 103, 3184-3192 (2008).
56. Branson, J. H. & Park, J. H. Sarcoidosishepatic involvement: presentation of a case with fatal liver involvement; including autopsy findings and review of the evidence for sarcoid involvement of the liver as found in the literature. Ann. Intern. Med. 40, 111-145 (1954).
57. Veitch, A. M. & Badger, I. Sarcoidosis presenting as colonic polyposis: Report of a case. Dis. Colon Rectum 47, 937-939 (2004). (Pubitemid 38702618)
58. Miller, L. K., Rochester, D. & Miller, J. W. Extensive abdominal lymphadenopathy in sarcoidosis. Am. J. Gastroenterol. 75, 367-369 (1981). (Pubitemid 11005292)
59. Lieberman, J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am. J. Med. 59, 365-372 (1975).
60. Gifre, L. et al. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review. Arch. Bronconeumol. 47, 208-212 (2011).
61. Ramos-Casals, M., Brito-Zeron, P., Soto, M. J., Cuadrado, M. J. & Khamashta, M. A. Autoimmune diseases induced by TNF-targeted therapies. Best Pract. Res. Clin. Rheumatol. 22, 847-861 (2008).
62. Massara, A., Cavazzini, L., La Corte, R. & Trotta, F. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review. Semin. Arthritis Rheum. 39, 313-319 (2010).
63. Izzi, S. et al. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy. Dermatol. Online J. 16, 16 (2010).
64. Perez-Alvarez, R., Perez-Lopez, R., Lombrana, J. L., Rodriguez, M. & Rodrigo, L. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J. Viral Hepat. 9, 75-79 (2002).
65. Yamada, S. et al. Hepatic sarcoidosis associated with chronic hepatitis C. J. Gastroenterol. 37, 564-570 (2002).
66. Luchi, S. & Scasso, A. Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases. Scand. J. Infect. Dis. 35, 775-776 (2003). (Pubitemid 37336913)
67. Menon, Y., Cucurull, E., Reisin, E. & Espinoza, L. R. Interferon-alpha-associated sarcoidosis responsive to infliximab therapy. Am. J. Med. Sci. 328, 173-175 (2004). (Pubitemid 39295865)
68. ten Hove, T, van Montfrans, C., Peppelenbosch, M. P. & van Deventer, S. J. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 50, 206-211 (2002). (Pubitemid 34087933)
69. Holland, S. M. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 38, 3-10 (2010).
70. Levine, S., Smith, V. V., Malone, M. & Sebire, N. J. Histopathological features of chronic granulomatous disease (CGD) in childhood. Histopathology 47, 508-516 (2005). (Pubitemid 41626729)
71. Damen, G. M. et al. Overlap, common features, and essential differences in pediatric granulomatous inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 51, 690-697 (2010).
72. Kuhns, D. B. et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363, 2600-2610 (2010).
73. Uzel, G. et al. Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease-related colitis. Clin. Infect. Dis. 51, 1429-1434 (2010).
74. Marciano, B. E. et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114, 462-468 (2004). (Pubitemid 39006676)
75. Marks, D. J. et al. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am. J. Gastroenterol. 104, 117-124 (2009).
76. Sodergren, M. H., Jethwa, P., Wilkinson, S. & Kerwat, R. Presenting features of Enterobius vermicularis in the vermiform appendix. Scand. J. Gastroenterol. 44, 457-461 (2009).
77. AbdullGaffar, B. Granulomatous diseases and granulomas of the appendix. Int. J. Surg. Pathol. 18, 14-20 (2010).
78. Dudley, T. H. Jr & Dean, P. J. Idiopathic granulomatous appendicitis, or Crohn's disease of the appendix revisited. Hum. Pathol. 24, 595-601 (1993). (Pubitemid 23162226)
79. Wettergren, A. et al. Granulomas of the appendix: is it Crohn's disease? Scand. J. Gastroenterol. 26, 961-964 (1991).
80. Bronner, M. P. Granulomatous appendicitis and the appendix in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 21, 98-107 (2004). (Pubitemid 40247212)
81. Borzutzky, A. et al. NOD2-associated diseases: Bridging innate immunity and autoinflammation. Clin. Immunol. 134, 251-261 (2010).
82. Saini, S. K. & Rose, C. D. Liver involvement in familial granulomatous arthritis (Blau syndrome). J. Rheumatol. 23, 396-399 (1996). (Pubitemid 26079229)
83. Punzi, L. et al. Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun. Rev. 8, 228-232 (2009).
84. Rose, C. D. et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J. Rheumatol. 32, 373-375 (2005). (Pubitemid 40209140)
85. Hizawa, K. et al. Suture granuloma in rectal anastomosis mistaken for locally recurrent cancer. J. Clin. Gastroenterol. 23, 78-79 (1996). (Pubitemid 26244513)
86. Jung, I. S., Kim, J. O., Lee, J. S., Lee, M. S. & Shim, C. S. Barium granuloma of rectum diagnosed by EUS. Gastrointest. Endosc. 57, 718-719 (2003).
87. Gutierrez, Y. et al. Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am. J. Surg. Pathol. 20, 603-612 (1996). (Pubitemid 26129448)
88. Berry, A. J., Long, E. G., Smith, J. H., Gourley, W. K. & Fine, D. P. Chronic relapsing colitis due to Strongyloides stercoralis. Am. J. Trop. Med. Hyg. 32, 1289-1293 (1983). (Pubitemid 14208873)
89. Kitsukawa, K. et al. Parasitic eosinophilic granuloma of the stomach resembling a submucosal tumor. Am. J. Gastroenterol. 85, 217-218 (1990). (Pubitemid 20067096)
90. Daniels, J. A., Lederman, H. M., Maitra, A. & Montgomery, E. A. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): A clinicopathologic study and review. Am. J. Surg. Pathol. 31, 1800-1812 (2007). (Pubitemid 350175807)
91. Carmen González-Vela, M., Fernando Val-Bernal, J., Francisca Garijo, M. & García-Suárez, C. Pyogenic granuloma of the sigmoid colon. Ann. Diagn. Pathol. 9, 106-109 (2005).
92. Moffatt, D. C., Warwryko, P. & Singh, H. Pyogenic granuloma: an unusual cause of massive gastrointestinal bleeding from the small bowel. Can. J. Gastroenterol. 23, 261-264 (2009).
93. Sanai, F. M. & Keeffe, E. B. Liver biopsy for histological assessment: The case against. Saudi J. Gastroenterol. 16, 124-132 (2010).
94. Neville, E., Piyasena, K. H. & James, D. G. Granulomas of the liver. Postgrad. Med. J. 51, 361-365 (1975).
95. Wainwright, H. Hepatic granulomas. Eur. J. Gastroenterol. Hepatol. 19, 93-95 (2007). (Pubitemid 46204323)
96. Dourakis, S. P. et al. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur. J. Gastroenterol. Hepatol. 19, 101-104 (2007). (Pubitemid 46204325)
97. Sanai, F. M. et al. Hepatic granuloma: decreasing trend in a high-incidence area. Liver Int. 28, 1402-1407 (2008).
98. Holtz, T., Moseley, R. H. & Scheiman, J. M. Liver biopsy in fever of unknown origin. A reappraisal. J. Clin. Gastroenterol. 17, 29-32 (1993). (Pubitemid 23193774)
99. Garcia-Ordonez, M. A. et al. Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin. J. Infect. 38, 94-98 (1999). (Pubitemid 29229633)
100. Vilades, C. et al. [Granulomatous hepatitis and fever of unknown origin]. An. Med. Interna 11, 334-337 (1994).
101. Sharma, S. in Hepatology: a Textbook of Liver Disease 4th edn (eds Zakim, D. & Boyer, T. D.) 1317-1330 (Elsevier, Philadelphia, 2003).
102. Amarapurkar, A. D. & Sangle, N. A. Histological spectrum of liver in HIV-autopsy study. Ann. Hepatol. 4, 47-51 (2005).
103. Cappell, M. S., Schwartz, M. S. & Biempica, L. Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am. J. Med. 88, 123-130 (1990). (Pubitemid 20051782)
104. Dincsoy, H. P., Weesner, R. E. & MacGee, J. Lipogranulomas in non-fatty human livers. A mineral oil induced environmental disease. Am. J. Clin. Pathol. 78, 35-41 (1982). (Pubitemid 12093116)
105. Delladetsima, J. K., Horn, T. & Poulsen, H. Portal tract lipogranulomas in liver biopsies. Liver 7, 9-17 (1987). (Pubitemid 17032016)
106. Denk, H. et al. Guidelines for the diagnosis and interpretation of hepatic granulomas. Histopathology 25, 209-218 (1994). (Pubitemid 24298431)
107. Sabharwal, B. D., Malhotra, N., Garg, R. & Malhotra, V. Granulomatous hepatitis: a retrospective study. Indian J. Pathol. Microbiol. 38, 413-416 (1995).
108. Sartin, J. S. & Walker, R. C. Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo Clinic. Mayo Clin. Proc. 66, 914-918 (1991).
109. Invernizzi, P., Lleo, A. & Podda, M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin. Liver Dis. 27, 161-172 (2007). (Pubitemid 46871662)
110. Guglielmi, V., Manghisi, O. G., Pirrelli, M. & Caruso M. L. [Granulomatous hepatitis in a hospital population in southern Italy]. Pathologica 86, 271-278 (1994).
111. Gaya, D. R., Thorburn, D., Oien, K. A., Morris, A. J. & Stanley, A. J. Hepatic granulomas: a 10 year single centre experience. J. Clin. Pathol. 56, 850-853 (2003). (Pubitemid 37386574)
112. Ozaras, R. et al. The prevalence of hepatic granulomas in chronic hepatitis C. J. Clin. Gastroenterol. 38, 449-452 (2004).
113. Tahan, V. et al. Prevalence of hepatic granulomas in chronic hepatitis B. Dig. Dis. Sci. 49, 1575-1577 (2004). (Pubitemid 39335537)
114. Drebber, U. et al. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis - a study of 442 cases. Liver Int. 28, 828-834 (2008). (Pubitemid 351818645)
115. Morimoto, Y. & Routes, J. M. Granulomatous disease in common variable immunodeficiency. Curr. Allergy Asthma Rep. 5, 370-375 (2005). (Pubitemid 41683980)
116. Guillevin, L. et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 78, 26-37 (1999). (Pubitemid 29065978)
117. Deniz, K., Ozseker, H. S., Balas, S., Akpynar, E. & Sokmensuer, C. Intestinal involvement in Wegener's granulomatosis. J. Gastrointest. Liver Dis. 16, 329-331 (2007). (Pubitemid 47518402)
118. Ebert, E. C., Hagspiel, K. D., Nagar, M. & Schlesinger, N. Gastrointestinal involvement in polyarteritis nodosa. Clin. Gastroenterol. Hepatol. 6, 960-966 (2008).
119. Costabel, U. Sarcoidosis: clinical update. Eur. Respir. J. Suppl. 32, 56s-68s (2001). (Pubitemid 34755186)
120. [No authors listed] BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60, 800-805 (2005).